Published in Medicine and Law Weekly, October 14th, 2005
The companies also agreed to settle the pending patent litigation with Organon and Savient concerning Barr Laboratories, Inc.'s generic version of Mircette, which the company markets under the trade name Kariva.
The parties also confirmed that they have requested,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.